Sebastian Stintzing
Ludwig-Maximilians-Universität München, LMU Klinikum, The Radiosurgery Society
Papers
8
Total Citations
145
H-Index
5
About
Sebastian Stintzing has established himself as a leading researcher in the minimally invasive treatment of metastatic colorectal cancer, with a particular focus on robotic radiosurgery and local ablative therapies for liver and pulmonary metastases. His body of work centers on evaluating and advancing stereotactic radiosurgery — most notably the CyberKnife system — as a viable alternative for patients with otherwise unresectable metastatic disease. Stintzing's most impactful contribution, a comparative study of robotic radiosurgery versus radiofrequency ablation in heavily pretreated colorectal liver metastasis patients (2013, 56 citations), helped define the clinical utility of these competing modalities. His early foundational studies from 2010 established the technical feasibility and value of frameless, single-session robotic radiosurgical approaches, collectively garnering over 60 citations. He further advanced the field by investigating diffusion-weighted MRI as a response assessment tool following radiosurgery, and by publishing rare long-term survival data that directly address questions of efficacy versus surgical resection. Spanning liver and pulmonary metastases across more than a decade of research, Stintzing's work has meaningfully shaped treatment paradigms for patients with advanced colorectal cancer who lack conventional surgical options.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8